TWiV 870: COVID-19 clinical update #103 with Dr. Daniel Griffin
About this episode
In COVID-19 clinical update #102, Daniel Griffin covers immunocompromised people, hospitalization of children, vaccine usage update, Omicron and cross-reactive neutralizing antibodies, reinfection prevents disease in hamsters, repeated infections with endemic coronaviruses, global burden of antimicrobial resistance, ivermectin not protective in hamsters, and Omicron evades therapeutic monoclonals.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- What does society owe immunocompromised people (Atlantic)
- Prevalence of immunosuppression in US (JAME)
- Hospitalizations of children (MMWR)
- Clinical considerations for vaccines (CDC)
- Sanofi seeks vaccine approval (Sanofi)
- Omicron triggers cross-reactive neutralization (medRxiv)
- Reinfection prevents disease in hamsters (Cell)
- Repeated infections with endemic CoV (J Inf Dis)
- Global burden of antimicrobial resistance (Lancet)
- Ivermectin not protective in hamsters (bioRxiv)
- Omicron evades therapeutic monoclonals (bioRxiv)
- Letters read on TWiV 870
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology